- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enveric Biosciences Inc (ENVB)
Assess today's live Enveric Biosciences Inc (ENVB) share price, performance and insights using our live NASDAQ: ENVB stock exchange data.
Analyse the historical data and Enveric Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Enveric Biosciences share price buy/sell indicators using real-time data (or discuss the Enveric Biosciences (ENVB) stock price today with other investors in the Enveric Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ENVB share price (ISIN: US29405E5050) to enhance your trading decisions with our free investment tools and resources.
What Is the Enveric Biosciences Inc Share Price Today?
The Enveric Biosciences share price today is 2.170.
What Is the Stock Symbol for Enveric Biosciences Inc
The stock symbol (or 'ticker') for Enveric Biosciences Inc is "ENVB."
What Stock Exchange Does Enveric Biosciences Inc Trade On?
Enveric Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Enveric Biosciences Inc a Good Stock to Buy?
Determining whether Enveric Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Enveric Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Enveric Biosciences share price buy/sell indicators using real-time data (or discuss the Enveric Biosciences (ENVB) stock price today with other investors in the Enveric Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ENVB share price (ISIN: US29405E5050) to enhance your trading decisions with our free investment tools and resources.
What Is the Enveric Biosciences Inc Share Price Today?
The Enveric Biosciences share price today is 2.170.
What Is the Stock Symbol for Enveric Biosciences Inc
The stock symbol (or 'ticker') for Enveric Biosciences Inc is "ENVB."
What Stock Exchange Does Enveric Biosciences Inc Trade On?
Enveric Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Enveric Biosciences Inc a Good Stock to Buy?
Determining whether Enveric Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
2.170
-0.060(-2.69%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.130
2.220
52 wk Range
1.710
17.640
ENVB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.1302.220
52 wk Range
1.71017.640
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ENVB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Form 8K Enveric Biosciences Inc For: 15 May
- Investing.com
- Form S-3 Enveric Biosciences Inc For: 23 April
- Investing.com
- Form 8K Enveric Biosciences Inc For: 15 May
- Investing.com
- Form S-1 Enveric Biosciences Inc For: 1 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
15/05/2026
EPS / Forecast
-1.08 / --
Revenue / Forecast
-- / --
Compare ENVB to Peers and Sector
Metrics to compare | ENVB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENVBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −2.4x | −0.5x | |
PEG Ratio | −0.01 | −0.03 | 0.00 | |
Price/Book | 1.6x | 2.6x | 2.6x | |
Price / LTM Sales | - | 3.1x | 3.1x | |
Upside (Analyst Target) | - | 100.9% | 53.2% | |
Fair Value Upside | Unlock | 4.2% | 6.2% | Unlock |
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Enveric Biosciences (NASDAQ: ENVB) Share Price Today?
The Enveric Biosciences stock price today is 2.170 USD.
What Stock Exchange Does Enveric Biosciences (ENVB) Trade On?
Enveric Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Enveric Biosciences?
The stock symbol (also called a 'ticker') for Enveric Biosciences is "ENVB."
What Is the Current Enveric Biosciences Market Capitalisation?
As of today, Enveric Biosciences (NASDAQ: ENVB) market cap is 7.920M USD.
What Is Enveric Biosciences's (ENVB) Earnings Per Share (TTM)?
The Enveric Biosciences EPS is currently -17.159 (Trailing Twelve Months).
Is ENVB a Buy or Sell From a Technical Analyst Perspective?
Based on today's Enveric Biosciences moving averages and other technical indicators, the daily buy/sell signal for ENVB stock is Strong Sell.
How Many Times Has Enveric Biosciences Stock Split?
Enveric Biosciences has split 7 times. (See the ENVB stock split history page for full effective split date and price information.)
How Many Employees Does Enveric Biosciences Have?
Enveric Biosciences has 6 employees, based on their latest Companies House report.
What is the current trading status of Enveric Biosciences (NASDAQ: ENVB)?
As of 27/05/2026, Enveric Biosciences (ENVB) is trading at a share price of 2.170 USD, with a previous close of 2.230 USD. The stock has fluctuated within a day range of 2.130 USD to 2.220 USD, while its 52-week range spans from 1.710 USD to 17.640 USD.
What Is the ENVB Premarket Price?
ENVB's last pre-market stock price is 2.210 USD. The pre-market share volume is 2,000.000, and the stock has decreased by -0.020, or -0.900%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.